Associations of average sleep duration and cumulative AIP with cardiometabolic multimorbidity risk in middle-aged and older Chinese adults: a CHARLS longitudinal study

For millions of people, the path to a healthy heart and metabolism is often mapped by what they eat, how much they move, and whether they smoke. Yet, a quieter, more fundamental rhythm of daily life has only recently stepped into the spotlight as a critical guardian of long-term health: sleep. Scientists now understand that sleep is not merely a period of rest, but an active biological process that helps regulate how the body handles sugar and fat, controls inflammation, and keeps blood vessels functioning smoothly. Alongside these behavioral factors, researchers have long tracked specific markers in the blood that signal trouble. One such marker, known as the atherogenic index of plasma, acts like a report card for the blood's tendency to clog arteries. It is calculated by comparing the amount of triglycerides, a type of fat, to the amount of high-density lipoprotein cholesterol, often called the "good" cholesterol. When this ratio is high, it suggests the body is struggling to manage its fats efficiently, a condition that paves the way for a cluster of serious conditions including diabetes, heart disease, and stroke. Understanding how these two distinct forces—the hours of rest we get and the state of our blood fats—interact to shape our future health is the central question driving new research into why some people develop multiple chronic diseases while others do not.

A team of researchers from Chengde Medical University and affiliated hospitals in China set out to untangle this relationship by looking at the lives of thousands of middle-aged and older adults. They turned to a massive, nationally representative database known as the China Health and Retirement Longitudinal Study, which has been tracking the health of Chinese citizens since 2011. The researchers focused on a specific group of people who were healthy at the start of the study, free from the cluster of conditions known as cardiometabolic multimorbidity. This term describes the simultaneous presence of at least two major health issues, such as heart disease, stroke, or diabetes. By following these individuals over several years, the team could observe who developed these conditions and look back at their sleep habits and blood fat levels to see what factors predicted the outcome.

The study involved 3,422 participants who provided detailed information about their lives and underwent blood tests at multiple points in time. Instead of relying on a single snapshot of their health, the researchers calculated a cumulative average for both sleep duration and the blood fat marker. This approach allowed them to capture a person's long-term habits rather than a temporary fluctuation. They divided the participants into groups based on how much they slept on average and how high their blood fat marker was. The results revealed a clear and powerful pattern: the longer a person slept on average, the lower their risk of developing these combined diseases became. Specifically, for every additional hour of sleep a person got on average, their risk of developing the condition dropped by roughly nine percent. Conversely, the blood fat marker told a different story. For every unit increase in this marker, the risk of developing the disease surged by nearly seventy percent.

Perhaps the most revealing part of the study was how these two factors worked together. The researchers found that sleep and blood fat levels operate as independent forces, each pulling the risk of disease in its own direction. However, the protective power of sleep was not felt equally by everyone. The data showed that getting more sleep provided a significant shield against disease only for those who already had low levels of the harmful blood fat marker. For individuals whose blood fat levels were already high, sleeping longer did not seem to offer the same protective benefit. In fact, for those with the highest levels of the blood fat marker, the amount of sleep they got made little difference to their risk; the danger remained high regardless of whether they slept a little or a lot. The group with the lowest risk was composed of people who had both low blood fat levels and slept for a moderate to long duration, roughly between six and a half to seven and a half hours a night.

This finding suggests that while sleep is a vital tool for maintaining health, it is not a magic bullet that can undo the damage of a severely disrupted metabolism. When the body's fat management system is already struggling, simply sleeping more may not be enough to reverse the trajectory toward disease. The researchers concluded that the best strategy for preventing these conditions involves a dual approach: managing lipid metabolism through diet and other means to keep blood fat markers low, while simultaneously ensuring adequate sleep. By addressing both the quality of rest and the state of the blood fats, doctors and individuals may be able to better predict and prevent the onset of multiple chronic diseases in the aging population. The study confirms that these two factors are distinct but essential pieces of the puzzle, and that keeping both in check offers the strongest defense for long-term health.